(Q50529100)

14 March 2018

title

The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. (English)

1 reference

14 March 2018

author name string

Epstein JB

1

1 reference

14 March 2018

Oakley C

2

1 reference

14 March 2018

Millner A

3

1 reference

14 March 2018

Emerton S

4

1 reference

14 March 2018

van der Meij E

5

1 reference

14 March 2018

Le N

6

1 reference

14 March 2018

publication date

1 May 1997

1 reference

14 March 2018

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

14 March 2018

volume

83

1 reference

14 March 2018

issue

5

1 reference

14 March 2018

page(s)

537-547

1 reference

14 March 2018

Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Smoking, alcohol, dentition and diet in the epidemiology of oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Dentition, diet, tobacco, and alcohol in the epidemiology of oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Mutagen Sensitivity in Patients With Head and Neck Cancers: A Biologic Marker for Risk of Multiple Primary Malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Leukoplakia revisited.A clinicopathologic study 3256 oral leukoplakias

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Follow-up of oral leukoplakia after carbon dioxide laser surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Leukoplakia-associated multiple carcinomas in patients with tongue carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Studies in oral leukoplakia: A preliminary report on the period pervalence of malignant transformation in leukoplakia based on a follow-up study of 248 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Oral leukoplakia and malignant transformation. A follow-up study of 257 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

CO2 laser treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Removal of oral soft tissue pathology with the CO2 laser

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Carbon dioxide laser resection of superficial oral carcinoma: indications, technique, and results

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Use of carbon dioxide laser for the treatment of premalignant lesions of the oral mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Carbon dioxide laser surgery of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Nd:YAG laser therapy of an oral verrucous leukoplakia.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Treatment of oral leukoplakia with topical bleomycin. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Topical bleomycin in the treatment of oral leukoplakia: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Topical treatment of oral leukoplakia with bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Oral precancer: preventive and medical approaches to management.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Oral vitamin A acid in treatment of dermatoses with pathologic keratinization

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Effect of retinoids on oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Retinoid inhibition of lingual carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Relationships of vitamins A and E and beta-carotene serum levels to head and neck cancer patients with and without second primary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Treatment of advanced squamous cell carcinoma of the skin with isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Biochemical treatment of precancerous oral lesions: The effectiveness of various analogues of retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Response of oral leukoplakias to the administration of vitamin A

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Snuff dippers keratosis (snuff-induced leukoplakia).

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Multiple primary cancers in patients with squamous cell carcinoma of the oral cavity.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Presentation Risk factors for second cancers of the upper respiratory and digestive systems: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Risk of multiple primary tumors following oral squamous-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Early detection, diagnosis, and management of oral and oropharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Second cancers following oral and pharyngeal cancer: patients' characteristics and survival patterns

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Chemoprevention of oral carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Multiple primary cancers in squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Second primary tumors in patients with oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Radiation therapy and pain in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Toluidine blue staining in the detection of oral precancerous and malignant lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

The Assessment of Diagnostic Tests

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Toluidine blue in the management of carcinoma of the oral cavity.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Use of meta-analysis to evaluate tolonium chloride in oral cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Factors affecting sensitivity and specificity of exercise electrocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Rethinking sensitivity and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Final evaluation of tolonium chloride rinse for screening of high-risk patients with asymptomatic squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Tolonium (toluidine blue) rinse--a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

The role of toluidine blue in assessing margin status after resection of squamous cell carcinomas of the upper aerodigestive tract.

1 reference

https://api.crossref.org/works/10.1016%2FS1079-2104%2897%2990117-7

7 January 2021

10.1016/S1079-2104(97)90117-7

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018